These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 22341736)

  • 1. Primary endpoint results of the EVOLVE trial: a randomized evaluation of a novel bioabsorbable polymer-coated, everolimus-eluting coronary stent.
    Meredith IT; Verheye S; Dubois CL; Dens J; Fajadet J; Carrié D; Walsh S; Oldroyd KG; Varenne O; El-Jack S; Moreno R; Joshi AA; Allocco DJ; Dawkins KD
    J Am Coll Cardiol; 2012 Apr; 59(15):1362-70. PubMed ID: 22341736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SYNERGY-Everolimus-Eluting Stent With a Bioabsorbable Polymer in ST-Elevation Myocardial Infarction: CLEAR SYNERGY OASIS-9 Registry.
    Jolly SS; Lee SF; Mian R; Kedev S; Lavi S; Moreno R; Montalescot G; Hillani A; Henry TD; Asani V; Storey RF; Silvain J; Spratt JCS; d'Entremont MA; Stankovic G; Zafirovska B; Natarajan MK; Sabate M; Shreenivas S; Pinilla-Echeverri N; Sheth T; Altisent OA; Ribas N; Skuriat E; Tyrwhitt J; Mehta SR
    Am J Cardiol; 2024 Jun; 220():111-117. PubMed ID: 38447893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Six-month IVUS and two-year clinical outcomes in the EVOLVE FHU trial: a randomised evaluation of a novel bioabsorbable polymer-coated, everolimus-eluting stent.
    Meredith IT; Verheye S; Weissman NJ; Barragan P; Scott D; Chávarri MV; West NE; Kelbæk H; Whitbourn R; Walters DL; Kubica J; Thuesen L; Masotti M; Banning A; Sjögren I; Stables RH; Allocco DJ; Dawkins KD
    EuroIntervention; 2013 May; ():. PubMed ID: 23688934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sirolimus-coated balloon in acute and chronic coronary syndromes: the PEACE study, a subanalysis of the EASTBOURNE registry.
    Laricchia A; Bossi I; Latini RA; Lee CY; Pérez IS; Tomai F; Nuruddin AA; Buccheri D; Seresini G; Ocaranza R; Sengottvelu G; Pesenti N; Mangieri A; Cortese B;
    Rev Esp Cardiol (Engl Ed); 2024 Jul; 77(7):527-536. PubMed ID: 38056772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design and Rationale of Targeted Therapy With a Sirolimus-Eluting, Biodegradable Polymer Coronary Stent in Chronic Total Occlusions (TARGET CTO): A Multicenter, Open-Label, Randomized Noninferiority Trial.
    Han Y; Wang G; Li Y; Zheng M; Cao R; Zhang R; Chen S; Wang J; Ma Y; Sun Z; Li X; Su X; Lu W; Xu Y; Spitzer E; Li X; Sun F
    J Soc Cardiovasc Angiogr Interv; 2022; 1(6):100511. PubMed ID: 39132368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel platinum chromium everolimus-eluting stent for the treatment of coronary artery disease.
    Bennett J; Dubois C
    Biologics; 2013; 7():149-59. PubMed ID: 23818756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current State of Bioabsorbable Polymer-Coated Drug-Eluting Stents.
    Akinapelli A; Chen JP; Roy K; Donnelly J; Dawkins K; Huibregtse B; Hou D
    Curr Cardiol Rev; 2017; 13(2):139-154. PubMed ID: 28017123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug-coated Balloon-only Angioplasty for Native Coronary Disease Instead of Stents.
    Wickramarachchi U; Eccleshall S
    Interv Cardiol; 2016 Oct; 11(2):110-115. PubMed ID: 29588716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Randomized Controlled Trial of Nonfasting vs Fasting Before Interventional Coronary Procedures: The TONIC Trial.
    Boukantar M; Chiaroni PM; Gallet R; Zamora P; Truong T; Mangiameli A; Rostain L; Tuffreau-Martin AS; Natella PA; Oubaya N; Teiger E
    JACC Cardiovasc Interv; 2024 May; 17(10):1200-1210. PubMed ID: 38811102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood compatibility assessment of polymers used in drug eluting stent coatings.
    Szott LM; Irvin CA; Trollsas M; Hossainy S; Ratner BD
    Biointerphases; 2016 Jun; 11(2):029806. PubMed ID: 27083991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Making evidence go further: Advancing synergy between agent-based modeling and randomized control trials.
    Hammond RA; Barkin S
    Proc Natl Acad Sci U S A; 2024 May; 121(21):e2314993121. PubMed ID: 38748574
    [No Abstract]   [Full Text] [Related]  

  • 12. The Power of Synergy.
    Avila-Ortiz G; Gonzalez-Martin O
    Int J Periodontics Restorative Dent; 2023 May; 43(3):278. PubMed ID: 38530328
    [No Abstract]   [Full Text] [Related]  

  • 13. Efficacy and safety of a novel bioabsorbable polymer-coated, everolimus-eluting coronary stent: the EVOLVE II Randomized Trial.
    Kereiakes DJ; Meredith IT; Windecker S; Lee Jobe R; Mehta SR; Sarembock IJ; Feldman RL; Stein B; Dubois C; Grady T; Saito S; Kimura T; Christen T; Allocco DJ; Dawkins KD
    Circ Cardiovasc Interv; 2015 Apr; 8(4):. PubMed ID: 25855680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Final five-year clinical outcomes in the EVOLVE trial: a randomised evaluation of a novel bioabsorbable polymer-coated, everolimus-eluting stent.
    Meredith IT; Verheye S; Dubois C; Dens J; Farah B; Carrié D; Walsh S; Oldroyd K; Varenne O; El-Jack S; Moreno R; Christen T; Allocco DJ
    EuroIntervention; 2018 Apr; 13(17):2047-2050. PubMed ID: 28923786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Six-month IVUS and two-year clinical outcomes in the EVOLVE FHU trial: a randomised evaluation of a novel bioabsorbable polymer-coated, everolimus-eluting stent.
    Meredith IT; Verheye S; Weissman NJ; Barragan P; Scott D; Valdés Chávarri M; West NE; Kelbæk H; Whitbourn R; Walters DL; Kubica J; Thuesen L; Masotti M; Banning A; Sjögren I; Stables RH; Allocco DJ; Dawkins KD
    EuroIntervention; 2013 Jul; 9(3):308-15. PubMed ID: 23872647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of a novel biodegradable polymer sirolimus-eluting stent with a durable polymer everolimus-eluting stent: results of the randomized BIOFLOW-II trial.
    Windecker S; Haude M; Neumann FJ; Stangl K; Witzenbichler B; Slagboom T; Sabaté M; Goicolea J; Barragan P; Cook S; Piot C; Richardt G; Merkely B; Schneider H; Bilger J; Erne P; Waksman R; Zaugg S; Jüni P; Lefèvre T
    Circ Cardiovasc Interv; 2015 Feb; 8(2):e001441. PubMed ID: 25634905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical outcomes with bioabsorbable polymer- versus durable polymer-based drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis.
    Palmerini T; Biondi-Zoccai G; Della Riva D; Mariani A; Sabaté M; Smits PC; Kaiser C; D'Ascenzo F; Frati G; Mancone M; Genereux P; Stone GW
    J Am Coll Cardiol; 2014 Feb; 63(4):299-307. PubMed ID: 24211507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Real-life clinical outcomes with everolimus eluting platinum chromium stent with an abluminal biodegradable polymer in patients from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR).
    Sarno G; Lagerqvist B; Olivecrona G; Varenhorst C; Danielewicz M; Hambraeus K; Lindholm D; Råmunddal T; Witt N; James S
    Catheter Cardiovasc Interv; 2017 Nov; 90(6):881-887. PubMed ID: 28544146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and efficacy of a bioabsorbable polymer-coated, everolimus-eluting coronary stent in patients with diabetes: the EVOLVE II diabetes substudy.
    Kereiakes DJ; Meredith IT; Masotti M; Carrié D; Moreno R; Erglis A; Mehta SR; Elhadad S; Berland J; Stein B; Airaksinen J; Jobe RL; Reitman A; Janssens L; Christen T; Dawkins KD; Windecker S
    EuroIntervention; 2017 Mar; 12(16):1987-1994. PubMed ID: 27840326
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.